CLINICAL_TRIALS
research
· 2026-02-10
Clinical Trial Update: Botulinum Neurotoxin for Children With CP: a Delicate Balance Between Clinical Benefits and Muscular Harm
Summary
A clinical trial is evaluating Botulinum Neurotoxin in children with spastic cerebral palsy, balancing potential clinical benefits with the risk of muscular har…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Spastic Cerebral Palsy (sCP) | Status: RECRUITING